SU-11652

SU-11652 Uses, Dosage, Side Effects, Food Interaction and all others data.

SU-11652 is a tyrosine kinase inhibitor.

Trade Name SU-11652
Generic SU-11652
Type
Formula C22H27ClN4O2
Weight Average: 414.928
Monoisotopic: 414.182253835
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
SU-11652
SU-11652

Innovators Monograph

You find simplified version here SU-11652



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5329103
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99444480
https://www.chemspider.com/Chemical-Structure.4486265.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4815
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=132084
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL13485
https://zinc.docking.org/substances/ZINC000003989259
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/J60
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime
(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime
(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE
(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE
(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime
4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE
3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine
(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
CT angiography - abdomen and pelvis
Lactic acid test
Free Light Chains
Mycobacterial culture
Audiometry
Chloride test - blood
Cholinesterase - blood
Sweat electrolytes test
Sputum stain for mycobacteria
Reticulocyte Count
Mild Streptococcal tonsillitis
Sports Massage
Hereditary
Inflammatory Reaction of the Nerve
Steroid resistant hepatic transplant rejection
Weight
Balanitis candida
Moderate Pneumocystis jiroveci pneumonia
severe Chronic Obstructive Pulmonary Disease (COPD)
Premedication